Richard Brudnick - Feb 27, 2025 Form 4 Insider Report for Prime Medicine, Inc. (PRME)

Role
Chief Business Officer
Signature
/s/ Karen Brown, attorney-in-fact
Stock symbol
PRME
Transactions as of
Feb 27, 2025
Transactions value $
$0
Form type
4
Date filed
3/3/2025, 08:12 PM
Previous filing
Dec 9, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRME Stock Option (right to buy) Award $0 +225K $0.00 225K Feb 27, 2025 Common Stock 225K $2.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of February 27, 2025, subject to the Reporting Person's continued service on each such vesting date.